|1.||Johnson, Richard J: 20 articles (12/2015 - 06/2002)|
|2.||Dalbeth, Nicola: 15 articles (10/2015 - 08/2006)|
|3.||Stamp, Lisa K: 13 articles (08/2015 - 02/2011)|
|4.||Day, Richard O: 11 articles (12/2015 - 01/2007)|
|5.||Becker, Michael A: 11 articles (10/2015 - 03/2005)|
|6.||Schumacher, H Ralph: 11 articles (08/2014 - 12/2005)|
|7.||Williams, Kenneth M: 10 articles (12/2015 - 01/2007)|
|8.||Graham, Garry G: 10 articles (12/2015 - 01/2007)|
|9.||van Bel, Frank: 10 articles (02/2014 - 11/2002)|
|10.||Choi, Hyon K: 9 articles (10/2015 - 01/2005)|
05/01/2014 - "Gouticin 500 mg twice daily is more effective than the allopurinol 300mg once daily in the management of gout."
03/01/2014 - "Gout is a major health problem in Polynesians and allopurinol, the drug of choice for the management gout, appears to be less effective in Polynesian patients. "
07/01/2014 - "Allopurinol is effective for the control of gout and its long-term complications when taken consistently. "
03/01/2005 - "Therapy with allopurinol has been effective for those manifestations the disease shares with gout. "
09/01/1989 - "We concluded that the intermittent administration of allopurinol as given here is less effective in controlling symptoms of gout than continuous therapy."
06/01/2013 - "Allopurinol is associated with a small but significant reduction in BP. This effect can be potentially exploited to aid in controlling BP in hypertensive patients with hyperuricemia."
01/01/2004 - "Therefore, allopurinol may be beneficial in the prevention of LDL oxidation, as well as in the treatment of hyperuricemia. "
04/01/1999 - "Allopurinol is effective in controlling hyperuricemia, but patients with higher initial Sur levels or taking concomitant diuretic therapy are less prone to reach therapeutic goals.Benzbromarone"
03/13/2015 - "Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine."
01/01/2014 - "We found that treatment of hyperuricemia with allopurinol is associated with an improvement in the endothelial-dependent, but not with the endothelial-independent vasodilatation."
07/01/1988 - "Allopurinol has been shown to provide significant protection against ischemia/reperfusion-induced microvascular and parenchymal cell injury. "
03/01/1991 - "In parallel, allopurinol treatment also improved ventricular developed pressure, peak systolic pressure, and coronary flow in isolated hearts subjected to 30 min of normothermic global ischemia and 30 min of reperfusion. "
10/01/1984 - "Allopurinol pretreatment thus affords some protection against ischemia-induced arrhythmias, but a higher degree of protection against reperfusion-induced arrhythmias. "
08/01/1990 - "To address this problem, we evaluated the protective effects of clinically used doses of enteral allopurinol in rats with intestinal ischemia. "
04/01/1990 - "We evaluated the protective effects of clinically used doses of enteral allopurinol in rats with intestinal ischemia. "
03/01/1995 - "Is allopurinol beneficial in the prevention of renal ischaemia-reperfusion injury in the rat?: evaluation by near-infrared spectroscopy."
07/01/1993 - "The present study suggests that allopurinol protection against ischemia-reperfusion injury may involve generalized alterations in tissue antioxidant status, and that the measurement of erythrocyte susceptibility to oxidative challenge could provide a useful approach to optimizing the effectiveness of therapeutic interventions undertaken prior to surgery in order to minimize the risk of damage resulting from postischemic tissue reperfusion."
08/01/1990 - "We conclude that enteral allopurinol in the presently available form and dose is effective in reducing mesenteric reperfusion injury."
04/01/1990 - "Allopurinol is effective in reducing reperfusion injury in the currently available enteral form in dose ranges that should not cause prohibitive side effects."
01/01/2013 - "Protective effects of reducing renal ischemia-reperfusion injury during renal hilar clamping: use of allopurinol as a nephroprotective agent."
|5.||Renal Insufficiency (Renal Failure)
09/01/2001 - "Allopurinol therapy successfully prevented further stone formation and significantly improved renal function in most patients with renal insufficiency. "
11/01/2013 - "Some trials have demonstrated an increased risk of allopurinol-induced adverse reactions in patients with CKD, whereas others have not confirmed renal insufficiency as a risk factor. "
04/01/2008 - "With regard to allopurinol, the dosage reduction is recommended in patients with renal insufficiency for preventing from rare adverse effect, bone marrow depression. "
04/01/2008 - "However, severe side effects of allopurinol may occur in patients with renal insufficiency. "
01/01/2006 - "From a clinical perspective, this syndrome is a distinctive interstitial nephropathy, inherited as an autosomal dominant trait, that progresses to renal failure and is not halted nor prevented by allopurinol therapy. "
|1.||Uric Acid (Urate)
|1.||Drug Therapy (Chemotherapy)
|2.||Psychology Biofeedback (Biofeedback)
|5.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)